What is FoundationOne?What?
How does FoundationOne work?How?
Why use FoundationOne?Why?
FoundationOne is a solid tumour profiling service that detects clinically relevant changes (genomic alterations) in cancer-related genes and helps to identify suitable therapies for a patient’s disease,1–3 by associating each alteration with the latest clinical and scientific evidence.4,5
FoundationOne can help to identify potentially effective targeted therapies, immunotherapies and investigational therapies for patients, driven by the knowledge of over 100 world-class experts.6 This information is presented in a curated, quality-controlled patient report explaining the biological relevance of each alteration in order to assist clinical decision-making.5
FoundationOne identifies clinically relevant genomic alterations in the majority of patients, potentially helping to expand treatment options for patients with metastatic or recurrent solid tumour cancer.7